These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30215792)

  • 1. Fatty-Acid Binding Protein 4 (FABP4) as a Potential Preclinical Biomarker of Drug-Induced Kidney Injury.
    Obajdin J; Cotter M; Snelling S; Dremier S; De Ron P; Fleurance R; Valentin JP; Nogueira da Costa A; Gryshkova V
    Toxicol Sci; 2018 Dec; 166(2):441-450. PubMed ID: 30215792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a Urinary Kidney MicroRNA Panel as Potential Nephron Segment-Specific Biomarkers of Subacute Renal Toxicity in Preclinical Rat Models.
    Glineur SF; Hanon E; Dremier S; Snelling S; Berteau C; De Ron P; Nogueira da Costa A
    Toxicol Sci; 2018 Dec; 166(2):409-419. PubMed ID: 30169741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of collecting duct injury in Han-Wistar and Sprague-Dawley rats treated with N-phenylanthranilic Acid.
    Betton GR; Ennulat D; Hoffman D; Gautier JC; Harpur E; Pettit S
    Toxicol Pathol; 2012 Jun; 40(4):682-94. PubMed ID: 22301952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue Kim-1 and urinary clusterin as early indicators of cisplatin-induced acute kidney injury in rats.
    Vinken P; Starckx S; Barale-Thomas E; Looszova A; Sonee M; Goeminne N; Versmissen L; Buyens K; Lampo A
    Toxicol Pathol; 2012 Oct; 40(7):1049-62. PubMed ID: 22581811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A scrutiny of circulating microRNA biomarkers for drug-induced tubular and glomerular injury in rats.
    Kagawa T; Zárybnický T; Omi T; Shirai Y; Toyokuni S; Oda S; Yokoi T
    Toxicology; 2019 Mar; 415():26-36. PubMed ID: 30682439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organic anion transporter 5 (Oat5) renal expression and urinary excretion in rats treated with cisplatin: a potential biomarker of cisplatin-induced nephrotoxicity.
    Bulacio RP; Torres AM
    Arch Toxicol; 2013 Nov; 87(11):1953-1962. PubMed ID: 23649842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of urinary biomarkers for nephrotoxicity in cynomolgus monkeys treated with gentamicin, cisplatin, and puromycin aminonucleoside.
    Uchino H; Fujishima J; Fukuoka K; Iwakiri T; Kamikuri A; Maeda H; Nakama K
    J Toxicol Sci; 2017; 42(5):629-640. PubMed ID: 28904298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats.
    Togashi Y; Sakaguchi Y; Miyamoto M; Miyamoto Y
    Exp Toxicol Pathol; 2012 Nov; 64(7-8):797-805. PubMed ID: 21377848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological and genetic inhibition of fatty acid-binding protein 4 alleviated cisplatin-induced acute kidney injury.
    Tan Z; Guo F; Huang Z; Xia Z; Liu J; Tao S; Li L; Feng Y; Du X; Ma L; Fu P
    J Cell Mol Med; 2019 Sep; 23(9):6260-6270. PubMed ID: 31286669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoprotein expression profiles in rat kidney injury: Source for potential mechanistic biomarkers.
    Gr